| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 8.54e-06 | 372 | 27 | 6 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.25e-05 | 398 | 27 | 6 | GO:0061659 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 3.32e-05 | 473 | 27 | 6 | GO:0004842 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 5.16e-05 | 512 | 27 | 6 | GO:0019787 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 5.81e-05 | 775 | 27 | 7 | GO:0016746 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 6.39e-05 | 532 | 27 | 6 | GO:0016755 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.24e-04 | 1189 | 27 | 8 | GO:0046914 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.39e-04 | 891 | 27 | 7 | GO:0008270 | |
| GeneOntologyMolecularFunction | GTPase binding | 1.31e-03 | 360 | 27 | 4 | GO:0051020 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.64e-03 | 231 | 27 | 3 | GO:0005085 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 4.53e-03 | 507 | 27 | 4 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 4.53e-03 | 507 | 27 | 4 | GO:0060589 | |
| GeneOntologyMolecularFunction | small GTPase binding | 9.05e-03 | 321 | 27 | 3 | GO:0031267 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 1.03e-02 | 1418 | 27 | 6 | GO:0030234 | |
| GeneOntologyBiologicalProcess | replication-born double-strand break repair via sister chromatid exchange | 4.26e-05 | 8 | 26 | 2 | GO:1990414 | |
| GeneOntologyBiologicalProcess | cellular response to testosterone stimulus | 1.18e-04 | 13 | 26 | 2 | GO:0071394 | |
| GeneOntologyBiologicalProcess | negative regulation of thymocyte apoptotic process | 1.18e-04 | 13 | 26 | 2 | GO:0070244 | |
| Domain | ZF_BBOX | 9.52e-08 | 80 | 27 | 5 | PS50119 | |
| Domain | Znf_B-box | 1.01e-07 | 81 | 27 | 5 | IPR000315 | |
| Domain | BBOX | 2.81e-06 | 69 | 27 | 4 | SM00336 | |
| Domain | - | 3.15e-06 | 71 | 27 | 4 | 4.10.45.10 | |
| Domain | zf-B_box | 3.33e-06 | 72 | 27 | 4 | PF00643 | |
| Domain | RING | 4.00e-06 | 305 | 27 | 6 | SM00184 | |
| Domain | Znf_RING | 5.87e-06 | 326 | 27 | 6 | IPR001841 | |
| Domain | - | 3.60e-05 | 449 | 27 | 6 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 4.07e-05 | 459 | 27 | 6 | IPR013083 | |
| Domain | ZF_RING_1 | 5.41e-05 | 291 | 27 | 5 | PS00518 | |
| Domain | ZF_RING_2 | 6.05e-05 | 298 | 27 | 5 | PS50089 | |
| Domain | Butyrophylin | 1.38e-04 | 70 | 27 | 3 | IPR003879 | |
| Domain | SPRY | 2.63e-04 | 87 | 27 | 3 | SM00449 | |
| Domain | SPRY | 3.31e-04 | 94 | 27 | 3 | PF00622 | |
| Domain | SPRY_dom | 3.31e-04 | 94 | 27 | 3 | IPR003877 | |
| Domain | B30.2/SPRY | 3.41e-04 | 95 | 27 | 3 | IPR001870 | |
| Domain | B302_SPRY | 3.41e-04 | 95 | 27 | 3 | PS50188 | |
| Domain | RCC1 | 3.76e-04 | 20 | 27 | 2 | PF00415 | |
| Domain | RCC1_3 | 4.16e-04 | 21 | 27 | 2 | PS50012 | |
| Domain | RCC1_1 | 4.16e-04 | 21 | 27 | 2 | PS00625 | |
| Domain | RCC1_2 | 4.16e-04 | 21 | 27 | 2 | PS00626 | |
| Domain | Reg_chr_condens | 4.57e-04 | 22 | 27 | 2 | IPR000408 | |
| Domain | - | 4.57e-04 | 22 | 27 | 2 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 5.00e-04 | 23 | 27 | 2 | IPR009091 | |
| Domain | ConA-like_dom | 3.78e-03 | 219 | 27 | 3 | IPR013320 | |
| Pubmed | 1.89e-07 | 15 | 27 | 3 | 19703589 | ||
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 4.01e-07 | 19 | 27 | 3 | 22144910 | |
| Pubmed | 1.74e-06 | 3 | 27 | 2 | 31461896 | ||
| Pubmed | 3.48e-06 | 4 | 27 | 2 | 23708797 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.07e-05 | 55 | 27 | 3 | 19468303 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.37e-05 | 774 | 27 | 6 | 15302935 | |
| Pubmed | 3.85e-05 | 503 | 27 | 5 | 16964243 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 5.51e-05 | 95 | 27 | 3 | 29643511 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 5.94e-05 | 1353 | 27 | 7 | 29467282 | |
| Pubmed | 6.06e-05 | 15 | 27 | 2 | 19762545 | ||
| Pubmed | TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. | 1.09e-04 | 20 | 27 | 2 | 25127057 | |
| Pubmed | Identification of novel ARF binding proteins by two-hybrid screening. | 1.21e-04 | 21 | 27 | 2 | 16582619 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.32e-04 | 394 | 27 | 4 | 27248496 | |
| Pubmed | 5.38e-04 | 44 | 27 | 2 | 25010285 | ||
| Pubmed | 5.45e-04 | 494 | 27 | 4 | 26831064 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 5.57e-04 | 497 | 27 | 4 | 36774506 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 5.61e-04 | 498 | 27 | 4 | 36634849 | |
| Pubmed | New insights on the functional role of URG7 in the cellular response to ER stress. | 6.14e-04 | 47 | 27 | 2 | 29704455 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 6.60e-04 | 1425 | 27 | 6 | 30948266 | |
| Pubmed | 6.70e-04 | 222 | 27 | 3 | 37071664 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 6.82e-04 | 934 | 27 | 5 | 33916271 | |
| Pubmed | 7.03e-04 | 1442 | 27 | 6 | 35575683 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 7.51e-04 | 954 | 27 | 5 | 36373674 | |
| Cytoband | 4q22.1 | 1.07e-04 | 26 | 27 | 2 | 4q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q22 | 8.76e-04 | 74 | 27 | 2 | chr4q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q14 | 3.81e-03 | 156 | 27 | 2 | chr11q14 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.24e-06 | 95 | 16 | 4 | 59 | |
| GeneFamily | Ring finger proteins | 8.25e-05 | 275 | 16 | 4 | 58 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.12e-07 | 856 | 27 | 9 | M4500 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 2.15e-07 | 656 | 27 | 8 | M18979 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 3.50e-07 | 466 | 27 | 7 | M13522 | |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 4.74e-05 | 197 | 27 | 4 | M8980 | |
| Coexpression | GSE3982_CTRL_VS_LPS_4H_MAC_DN | 4.93e-05 | 199 | 27 | 4 | M5368 | |
| Coexpression | BURTON_ADIPOGENESIS_9 | 9.10e-05 | 85 | 27 | 3 | M1666 | |
| Coexpression | BURTON_ADIPOGENESIS_9 | 1.04e-04 | 89 | 27 | 3 | MM1026 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 4.22e-06 | 98 | 24 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.97e-05 | 192 | 24 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 8.02e-05 | 989 | 24 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 2.04e-04 | 498 | 24 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.87e-06 | 165 | 27 | 4 | 1dcd6b8aa192baeaa1f7bb334843edab6049b96f | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-06 | 173 | 27 | 4 | 279efbab7810fa60ab12ea5d09a84800df4adef0 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-06 | 176 | 27 | 4 | 6548797336c9f4ca0f38e74a2c629e2a4defa252 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.41e-06 | 184 | 27 | 4 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.61e-06 | 186 | 27 | 4 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 6.02e-06 | 199 | 27 | 4 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 151 | 27 | 3 | b4a0546c1573b4b2290890307f2a5daf3a7cbb37 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 151 | 27 | 3 | 7758cfbe8dca849c90bd6e8bc63310e53beeb8fd | |
| ToppCell | droplet-Liver-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 152 | 27 | 3 | 1febeeb7376e34b9f86c81b2cb1314ee12408864 | |
| ToppCell | droplet-Liver-nan-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 152 | 27 | 3 | faa92f7c5a6db9f1eb7d8ec930ba7c8ed9fd1bf1 | |
| ToppCell | Myeloid-F|World / shred on cell class and cell subclass (v4) | 1.08e-04 | 154 | 27 | 3 | 6d53eec4aefe54836bbfd314f28f5e9a24c2d833 | |
| ToppCell | Myeloid-Myeloid-F|Myeloid / shred on cell class and cell subclass (v4) | 1.13e-04 | 156 | 27 | 3 | d6317843ae5c5749452889e768c187a9d9e8c7fe | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-04 | 162 | 27 | 3 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | droplet-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 163 | 27 | 3 | a794540f2d8984f963c08f05175e4bc916fcc224 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-04 | 166 | 27 | 3 | afba41e15478053f11815acf568d29187de75492 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 171 | 27 | 3 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 172 | 27 | 3 | 584af6537685cb459bf0fc298e6f46872016c116 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_TH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 175 | 27 | 3 | 02c67a10cbe849fbf38f082f42517e42483e8cb7 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.58e-04 | 175 | 27 | 3 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-04 | 176 | 27 | 3 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-04 | 176 | 27 | 3 | b0b87eebcf5c994386b39ca607e17f10e9d9de74 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-04 | 177 | 27 | 3 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-04 | 177 | 27 | 3 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | LPS-antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 178 | 27 | 3 | 289d1425c4e57fabcca994b27f9af1c0ce5d5bec | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 178 | 27 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_TH|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-04 | 179 | 27 | 3 | 797d165718dd1d819e65add3a7859f87b32238a5 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.72e-04 | 180 | 27 | 3 | cc31d2cd06161300b91b17a67bb432b75f0d719b | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-04 | 182 | 27 | 3 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 182 | 27 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-04 | 182 | 27 | 3 | 94d061b7b5ebbfc564c644bc8b2d52341927145d | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 184 | 27 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-04 | 185 | 27 | 3 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 1.89e-04 | 186 | 27 | 3 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 187 | 27 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.01e-04 | 190 | 27 | 3 | 373629dde5eda722424c5e6087763f0c5db67cf4 | |
| ToppCell | CD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.27e-04 | 198 | 27 | 3 | 3d1749f5106f0912f4a74615863853949f52c73d | |
| ToppCell | Severe_COVID-19|World / Disease group,lineage and cell class (2021.01.30) | 2.27e-04 | 198 | 27 | 3 | 09fd456077bb3a657ad3b10c6cfe799b7266456a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-04 | 198 | 27 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.27e-04 | 198 | 27 | 3 | 454aee3f4fe6d0beeccc55200b4495f4f9b44feb | |
| ToppCell | BAL-Severe|BAL / Compartment, Disease Groups and Clusters | 2.27e-04 | 198 | 27 | 3 | f63cfcc57f46094ea0673bbc70ea443ebaca6176 | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.27e-04 | 198 | 27 | 3 | 687f69c16343227854c882b4a0f3930ce534a3d2 | |
| ToppCell | CV|World / Virus stimulation, Condition and Cluster | 2.27e-04 | 198 | 27 | 3 | 6a28193af35abec5c029129930c2ca6febaafde2 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.27e-04 | 198 | 27 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Severe|World / Condition, Lineage, Cell class and cell subclass | 2.31e-04 | 199 | 27 | 3 | a8b87f4f504a3b0ad6013277f0c9f543db3ef1fb | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.31e-04 | 199 | 27 | 3 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.31e-04 | 199 | 27 | 3 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Severe|World / Disease group and Cell class | 2.31e-04 | 199 | 27 | 3 | b73ae402b258fcc17e6cd6d6045244eccfe38ef8 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.31e-04 | 199 | 27 | 3 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.34e-04 | 200 | 27 | 3 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-TH--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.34e-04 | 200 | 27 | 3 | e9b5105fff7845a98f962d609c2055528583b48e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.34e-04 | 200 | 27 | 3 | 1a04331862079092bc04b1010aa9228c0fa3d8c5 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.34e-04 | 200 | 27 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.34e-04 | 200 | 27 | 3 | fb56d430957e73fba17db7bc0127ecf3577e0867 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.34e-04 | 200 | 27 | 3 | 05bcde6ce8f1354ef65e4eb9cbd963a92108081c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-TH-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.34e-04 | 200 | 27 | 3 | fa0d4a0c93b0b0ad0331e7b7013373be27958c4e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-TH|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.34e-04 | 200 | 27 | 3 | 3ece392f336547aea7dea625d9102819b04b4f7a | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.34e-04 | 200 | 27 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; HL60; HG-U133A | 2.55e-06 | 196 | 26 | 5 | 1422_DN | |
| Disease | Leukoencephalopathy | 4.41e-05 | 11 | 27 | 2 | C0270612 | |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 7.29e-05 | 14 | 27 | 2 | C1858991 | |
| Disease | Lung Neoplasms | 1.79e-03 | 265 | 27 | 3 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.81e-03 | 266 | 27 | 3 | C0242379 | |
| Disease | multiple sclerosis (is_implicated_in) | 2.04e-03 | 73 | 27 | 2 | DOID:2377 (is_implicated_in) | |
| Disease | preeclampsia | 2.32e-03 | 78 | 27 | 2 | EFO_0000668 | |
| Disease | Drug toxicity | 2.68e-03 | 84 | 27 | 2 | C0013221 | |
| Disease | Adverse reaction to drug | 2.68e-03 | 84 | 27 | 2 | C0041755 | |
| Disease | Acute kidney injury | 3.85e-03 | 101 | 27 | 2 | C2609414 | |
| Disease | Kidney Failure, Acute | 3.85e-03 | 101 | 27 | 2 | C0022660 | |
| Disease | Acute Kidney Insufficiency | 3.85e-03 | 101 | 27 | 2 | C1565662 | |
| Disease | Liver Cirrhosis | 4.00e-03 | 103 | 27 | 2 | C0023890 | |
| Disease | Fibrosis, Liver | 4.15e-03 | 105 | 27 | 2 | C0239946 | |
| Disease | pancreatic cancer (is_implicated_in) | 4.71e-03 | 112 | 27 | 2 | DOID:1793 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RAVPEEMELAKEEKC | 371 | Q12882 | |
| SKPREDMECDDLKEL | 396 | Q9NRL2 | |
| HEDMLVVDPKSKEED | 281 | P10451 | |
| HCSEEKEDEDYMPIK | 391 | Q8WUA2 | |
| FKLLMEHLDPDEEEE | 2621 | Q6KC79 | |
| KEMEHVLDPDSELCA | 1441 | Q6ZVL6 | |
| MCDEDIIKLFHPEEL | 891 | Q9UII4 | |
| EFEKAMKELAEEEPH | 86 | P40855 | |
| MEHICKLIDTIPDDK | 376 | P54132 | |
| DNKIMCHDDDDKDPV | 586 | Q6IQ26 | |
| KAMDKHNLEEEEPED | 831 | Q12967 | |
| EEMKKGHLERECMEE | 46 | P00742 | |
| EMEPQDLELELCKKH | 96 | Q9Y2H2 | |
| EDVEPECIMEKVAKA | 121 | Q9UJU6 | |
| VEKLVKMIPCEHEDL | 346 | Q92845 | |
| EELNEMCHKPDVELL | 231 | P0CI25 | |
| HEELMLGDPCLKDLK | 651 | P07814 | |
| LSCEQEKPMHLEIED | 176 | Q969F1 | |
| LSMLKEPPLHEKCED | 3121 | O75592 | |
| HIMEDCDLKEPEGLL | 241 | Q96F83 | |
| EKKSDQPMCEEHEEE | 116 | Q9BYV6 | |
| YDHLDPTEMEKVEKC | 726 | O95757 | |
| EELNEMCHKPDVELL | 231 | P0CI26 | |
| EDCMAKELPEHTVKL | 271 | P02774 | |
| HKDHMDKKEEIIAPC | 1301 | O75116 | |
| EHPDMLDEKDCLKEV | 846 | Q86X10 | |
| EELNEMCHKPDVELL | 231 | A6NDI0 |